WALTHAM, MA – The Alzheimer’s Association Massachusetts/New Hampshire Chapter is pleased with the decision by the Baker Administration to include caregivers in the current phase 2 eligibility pool to receive the COVID-19 vaccination. The administration announced Wednesday that individuals who accompany someone age 75 or older to get a vaccine at a mass vaccination site may also schedule and receive their own vaccination on the same day.
“We recognize this updated measure is an important step to ensure this oldest tier of the population is vaccinated as soon as possible and commend the inclusion of caregivers in that process,” said Dan Zotos, Director of Public Policy and Advocacy for the Alzheimer’s Association MA/NH Chapter. “We will continue to advocate for Alzheimer’s and dementia to be more broadly included in the vaccine rollout process and have particular concern for those with younger-onset and their caregivers living at home.”
The Alzheimer’s Association strongly supports the decision to prioritize caregivers for receiving the vaccine, a critical step in protecting the health and safety of our state’s most vulnerable and the individuals caring for them. There are currently 130,000 people living with Alzheimer’s disease in Massachusetts, and 340,000 individuals providing their care.
New research published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association found that risk of contracting COVID-19 was twice as high for people living with dementia than those without it. These findings, though preliminary, suggest a frightening reality of the vulnerabilities associated with living with dementia. The Alzheimer’s Association Massachusetts/New Hampshire Chapter continues to advocate for individuals living with younger-onset Alzheimer’s, typically aged 65 and younger, to be eligible to receive the COVID-19 vaccination in Phase 2.
About the Alzheimer's Association®
The Alzheimer’s Association leads the way to end Alzheimer’s and all other dementia – by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia. Visit alz.org or call 800.272.3900.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.